MedRhythms, which is pioneering rhythmic auditory stimulation to improve walking ability in people with neurological disorders, has now launched a partnership with Universal Music Group (UMG) — owner of a vast catalog of recordings and songs — to expand its prescription music offerings to patients. The collaboration will allow…
Hartford Healthcare has been awarded a Parkinson Voice Project 2021 SPEAK OUT! & LOUD Crowd grant — which the Connecticut healthcare network will use to expand its speech therapy programs. Each clinic awarded one of the more than 200 global SPEAK OUT! & LOUD Crowd grants receives therapy…
A molecule showed a potential in early studies to slow the production of alpha-synuclein, a protein that forms large toxic aggregates in the brains of  people with Parkinson’s disease, a research team reported. Called A-443654, the molecule lowered to normal levels the protein’s production in nerve cells derived from a…
A scientist from the University of California San Diego, whose research has focused on an enzyme seen as a primary genetic driver of Parkinson’s disease, will receive approximately $9 million in funding over the next seven years as a new Howard Hughes Medical Institute (HHMI) investigator. Elizabeth Villa,…
The response of the eyes’ pupils — the black circle in the center of the eye  that allows light to enter — seems to change according to the progression of Parkinson’s disease, a recent study has found. The results suggest that measuring the pupils’ response to stimuli could become a noninvasive…
The Parkinson’s Foundation is launching a four-year, $30-million fundraising campaign to help advance Parkinson’s research and fund community services. The Reach Further campaign seeks to help accelerate research, increase patient access to healthcare, and enrich community services for those affected by Parkinson’s disease. “With the rate of…
A newly launched five-year, $3 million collaboration, called ENIGMA-PD, will investigate brain imaging, genetics, and clinical data in a global study of Parkinson’s disease. Research efforts in more than 20 countries will be combined in the new project, created by the University of Southern California’s Mark and Mary…
The use of non-steroidal anti-inflammatory drugs (NSAIDs) seems to have no effect on the incidence of Parkinson’s disease, according to a large retrospective Norwegian study. Researchers focused on the NSAIDs prescribed most in Norway: diclofenac, ibuprofen, and naproxen. In the study “NSAID use is not associated with Parkinson’s…
A new type of artificial intelligence (AI) algorithm, developed by the Mayo Clinic and the Google Research Brain Team, can potentially pave the way toward more directed brain stimulation for the treatment of Parkinson’s disease and other movement-related disorders. According to researchers, this algorithm can more accurately determine…
Get regular updates to your inbox.